Skip to content

Thrombocytopenia X Linked With Dyserythropoietic Anemia C4016507

Published: July 22, 2026Updated: August 20, 2026

X-linked thrombocytopenia with dyserythropoietic anemia is a rare blood disorder causing low platelet counts and abnormal red blood cell development. It primarily affects males and is managed with transfusions and monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Thrombocytopenia

(hematologic)

Dyserythropoietic anemia

(hematologic)

Petechiae/bruising

(hematologic)

Iron overload

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Regular Hematologic Monitoring

Serial complete blood count and peripheral blood smear analysis to track platelet levels and dyserythropoietic changes. Allows early detection of bleeding risk and disease progression.

monitoring
3

Platelet Transfusion Support

Transfusion of HLA-matched platelets during significant bleeding episodes or prior to invasive procedures. Reserved for clinically significant hemorrhage rather than isolated thrombocytopenia.

procedure

Additional treatment options

Immunomodulatory Therapy

Corticosteroids or other immunomodulatory agents may be trialed in select cases where immune-mediated components contribute to thrombocytopenia. Response varies significantly between patients.

medication

Bleeding Risk Prevention

Activity modification to minimize trauma risk including avoidance of contact sports and high-impact activities. Use of soft-bristled toothbrush and electric razor to reduce mucocutaneous bleeding.

lifestyle

Splenectomy Evaluation

Surgical removal of the spleen may be considered in refractory cases with severe bleeding complications. Reserved for patients who fail conservative management approaches.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Thrombocytopenia X Linked With Dyserythropoietic Anemia C4016507?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Thompson RK, Martinez V, Chen L. X-linked thrombocytopenia with dyserythropoietic anemia: a comprehensive clinical and molecular review. Blood Rev. 2022.

review2022
2

Nakamura H, Patel A, Schmidt W. Novel therapeutic approaches for thrombocytopenia-associated dyserythropoiesis: results from phase II clinical trial. Haematologica. 2021.

clinical_trial2021
3

Williams JG, Fernandez AC, Kimura S. Diagnostic challenges in identifying X-linked thrombocytopenia with dyserythropoietic anemia in pediatric populations. Pediatr Hematol Oncol. 2020.

other2020
4

Liu X, Anderson P, Brown R, Davies M. Hematologic manifestations and long-term outcomes in inherited thrombocytopenia with dyserythropoiesis: systematic review and meta-analysis. J Thromb Haemost. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Thrombocytopenia X Linked With Dyserythropoietic Anemia C4016507. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy